1. Home
  2. CTS vs COLL Comparison

CTS vs COLL Comparison

Compare CTS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTS Corporation

CTS

CTS Corporation

HOLD

Current Price

$48.36

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$45.57

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTS
COLL
Founded
1896
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CTS
COLL
Price
$48.36
$45.57
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$51.17
AVG Volume (30 Days)
158.2K
484.7K
Earning Date
02-03-2026
02-26-2026
Dividend Yield
0.33%
N/A
EPS Growth
3.07
N/A
EPS
1.98
1.63
Revenue
$531,522,000.00
$757,067,000.00
Revenue This Year
$5.73
$26.17
Revenue Next Year
$4.00
$3.65
P/E Ratio
$24.38
$28.05
Revenue Growth
3.61
26.34
52 Week Low
$34.02
$23.23
52 Week High
$53.28
$50.79

Technical Indicators

Market Signals
Indicator
CTS
COLL
Relative Strength Index (RSI) 72.40 44.54
Support Level $46.28 $45.00
Resistance Level $49.14 $49.17
Average True Range (ATR) 1.06 1.97
MACD 0.35 -0.31
Stochastic Oscillator 87.98 16.81

Price Performance

Historical Comparison
CTS
COLL

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: